Suven Life Sciences - Quaterly Results

08 Aug 2023 Evaluate
The Revenue for the quarter ended  June 2023 of Rs. 37.97 millions grew by 7.29 % from Rs. 35.39 millions.The Net Loss for the quarter ended June 2023 is Rs. -28.71 millions as compared to Net Loss of Rs. -23.13 millions of corresponding quarter ended June 2022 Operating profit Margin for the quarter ended June 2023 further decreased to -11.55% as compared to -66.30% of corresponding quarter ended June 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 37.97 35.39 7.29 37.97 35.39 7.29 135.39 118.44 14.31
Other Income 56.40 4.36 1193.58 56.40 4.36 1193.58 84.49 16.01 427.73
PBIDT -11.55 -66.30 -82.58 -11.55 -66.30 -82.58 -192.95 -350.41 -44.94
Interest 0.51 1.02 -50.00 0.51 1.02 -50.00 2.89 5.30 -45.47
PBDT -12.06 -7.32 64.75 -12.06 -7.32 64.75 -135.84 -318.55 -57.36
Depreciation 16.65 15.81 5.31 16.65 15.81 5.31 65.43 43.93 48.94
PBT -28.71 -23.13 24.12 -28.71 -23.13 24.12 -201.27 -362.48 -44.47
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -28.71 -23.13 24.12 -28.71 -23.13 24.12 -201.27 -362.48 -44.47
Equity 218.07 145.38 50.00 218.07 145.38 50.00 218.07 145.38 50.00
PBIDTM(%) -30.42 -187.34 -83.76 -30.42 -187.34 -83.76 -142.51 -295.85 -51.83

Suven Life Sciences Share Price

147.70 -2.25 (-1.50%)
26-Feb-2026 13:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1774.05
Dr. Reddys Lab 1314.60
Cipla 1351.50
Zydus Lifesciences 931.10
Lupin 2312.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×